Multiple Sclerosis (MS) is a chronic autoimmune disease of the Central Nervous System (CNS) that affects approximately 400,000 people in the United States, and presents in several forms with the most prevalent being Relapse-Remitting (RR-MS) that affects nearly 85% of all MS patients. RR-MS is characterized by periods of debilitating disease symptoms followed by extended periods of remission. The second most common form is chronic progressive MS, with approximately 15% of the patients presenting with this form; most RR-MS patients develop progressive disease after several decades. This CNS disorder has no known etiology. However, there is prevalence among populations living in higher latitudes, and exposure to vitamin D by sunlight, or lack thereof, has been suggested as a factor in the development of MS. Statistics show that MS affects white women more than women of color, and that MS afflicts women more than men by a 3:1 ratio.
Journal of Multiple sclerosis is one of the best upcoming neurology journals that deal with the various contemporary issues about this disease. This quarterly journal covers different issues and themes in every issue. Journal of Multiple sclerosis is an open access journal that follows appropriate peer review process for the acceptance of the articles.
Last date updated on June, 2014